From metformin to basal insulin to overlooked older medications, this episode reviews the T2D medication toolkit clinicians use every day. We then dive into new evidence on once-weekly insulin to help you individualize therapy while reducing treatment burden.

🔹 Sponsor: Pain Management and Opioids Adaptive Learning Free Online Course by NEJM Group: https://cme-info.nejm.org/core-im/

🔹Transcript and Shownotes:

00.58 | Insulin Hx & Types

06:00 | Indications for Insulin and the Burden on Patients

08:26 | What is the QWINT-1 Trial?

16:18 | Discussion

Tags: CoreIM, Internal Medicine, Evidence-Based Medicine, Insulin Resistance, Clinical Reasoning, Hospital Medicine, Medical Education, Endocrine, Endocrinology

Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840

Our Sponsors:
* Check out Branch Basics and use my code branchbasics.com/COREIM for a great deal: https://branchbasics.com
* Check out Quince for high-quality clothes with affordable pricing and use code quince.com/coreim

Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

#200: Insulin and QWINT-1 Trial in T2DM: Beyond Journal Club Segment with NEJM Group

Core IM | Internal Medicine Podcast

#200: Insulin and QWINT-1 Trial in T2DM: Beyond Journal Club Segment with NEJM Group